Generic drug manufacturer KV Pharmaceutical Company expands recall

ETHEX Corporation, a subsidiary of KV Pharmaceutical Company (NYSE: KVa; KVb), is issuing a voluntary expansion to the retail level of a previously announced recall on certain products. The recall on the products listed below had previously been issued to the wholesale level, but is now being expanded to the retail level. The Company is taking this action as a precautionary measure, because the products may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practice (cGMP). This additional level of recall is to further remove recalled products from the marketplace.

Patients who may have these products in their possession should continue to take them in accordance with their prescriptions, as the risk of suddenly stopping needed medications may place patients at risk. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these products. Lawyers for the company could not be reached for comment.

Expanded Recall to Retail Level Includes the Following Products:

Morphine Sulfate Extended-Release Tablets 15mg, 30mg & 60mg (All Strengths)

Morphine Sulfate Immediate-Release Tablets 15mg & 30 mg (All Strengths)

Dextroamphetamine Sulfate Tablets 5mg & 10mg (All Strengths)

Isosorbide Mononitrate Extended-Release Tablets 30mg, 60mg & 120mg (All Strengths)

Propafenone HCl Tablets 150mg, 225mg & 300 mg (All Strengths)

Any retail customer inquiries related to this action should be addressed to ETHEX Customer Service at 1-800-748-1472, faxed to ETHEX Customer Service at 314-646-3788, or e-mailed to [email protected] Representatives are available Monday through Friday, 8 am to 5 pm CST.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). At this time, the Company is unable to determine when distribution of these products will resume.

Patients with questions about the recall should call the telephone number above, or contact their healthcare providers. Any adverse reactions experienced with the use of these products should also be reported to FDA’s MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.



, ,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Heightened Thrombosis Risk with Birth Control Patch and Ring

A BMJ study has found more evidence that women using the transdermal contraceptive patch or vaginal ring do indeed face higher thrombosis risks than those taking their contraceptive orally. Using Danish national registries, researchers studied over 1.5 million women without prior thrombotic disease or cancer, who were not pregnant. Overall, the incidence of venous thrombosis [...]

Is Your Heartburn Medication Putting You At Risk?

According to a new study, your heartburn medication could be putting you at risk for a nasty stomach bug! The infection, Clostridium difficile infection, also called C. difficile or CDI, is a hard-to-cure infection that causes severe diarrhea that has recently been linked to proton pump inhibitors (PPIs), the most powerful class of antacid drugs. [...]

Cipralex and Abnormal Heart Rhythms

Health Canada is informing Canadians of a labeling update for the prescription drug Cipralex (Escitalopram) regarding a dose-related risk of abnormal heart rhythms. The risk is dose-related, 20 mg per day is still the maximum recommended dose for most patients. Before starting Cipralex, talk to your healthcare professional. If you have had any heart problems, what other medications you [...]

Florida Compounding Pharmacy Linked To Rare Fungal Eye Infections

Whats that in my eye?! Thirty-three cases of a rare, but serious, fungal eye infection have been confirmed across seven states. Federal officials are announcing that the infection stemmed from products mixed in a Florida compounding pharmacy. it seems the victims underwent some sort of an eye procedure, either a surgery or injections. Of these, [...]

Multaq and Death By Heart Problems

Multaq, also known as Dronedarone, is used to treat heart patients that had atrial fibrillation, which is a rhythm disorder that could make the heart beat fast and irregular. It’s also used to treat atrial flutter, which also causes the heart to beat fast, but is still considered regular. However, this drug is known to [...]

Latest Medical Device Injury News

More Sufferers File Lawsuits Against DePuy Orthopaedics

Two more people who’ve suffered serious injuries blamed on the defective and recalled DePuy Orthopaedics ASR hip implant are the latest to join a growing federal class-action lawsuit against the medical device firm and its parent company, Johnson & Johnson. The plaintiff’s are being represented by the law firm of Parker Waichman LLP and are [...]

Metal-on-Metal Hip Implant Finds No Increased Cancer Risk?

We have written countless articles discussing the dangers of metal-on-metal implants, yet a new study is downplaying the potential dangerous effects, such as the risk of cancer. The recent study was published in the British Medical Journal which analyzed cancer rates among patients with metal-on-metal implants versus patients with other types of implants as well [...]

St. Jude’s Wants Study Retracted Due To Inaccuracy

St. Jude Medical has asked the Heart Rhythm Journal to retract a study published last month that linked its Riata line of internal defibrillator leads to more 20 deaths. In a statement issued by St. Jude, the company asserted the Riata lead study was biased and based on inaccurate facts. According to the Heart Rhythm [...]

Vaginal Mesh Lawsuits Claim Painful Erosion, Organ Damage

An estimated 35,000 women who suffered through bladder control problems brought on by aging, child birth, and a variety of other causes. The lives of those who had adverse reactions to vaginal mesh were literally ruined as many experienced crippling pain and permanent scarring damage from the procedures involved in the insertion and necessary removal of the vaginal mesh.

If you or a loved one suffered vaginal erosion call us immediately at 1-800-810-3457.

FDA Reposts Thoratec HeartMate II LVAS Class I Recall

A recall of Thoratec’s HeartMate II Left Ventricle Assist System (LVAS) that was first announced in February has been designated Class I, the U.S. Food & Drug Administration’s (FDA) most serious type of recall. The HeartMate II LVAS is a heart pump which is used as a bridge to transplantation in heart transplant candidates at [...]